CYTK Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 461 min ago

@ $65.14

Wydano: 3 geg. 2024 @ 21:59

Zwrot: 0.20%

Poprzedni sygnał: geg. 2 - 20:11

Poprzedni sygnał: Sprzedaż

Zwrot: 1.09 %

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	880 263
Średni wolumen	1.97M
Kapitalizacja rynkowa	6.83B
EPS	$0 ( 2024-05-02 )
Następna data zysków	( $-1.160 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-11.98
ATR14	$1.601 (2.45%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-26	Lee Sung	Buy	0
2024-04-25	Henderson John T	Sell	10 562	Common Stock
2024-04-12	Malik Fady Ibraham	Sell	150	Common Stock
2024-04-09	Malik Fady Ibraham	Buy	28 605	Common Stock
2024-04-09	Malik Fady Ibraham	Sell	28 605	Common Stock

INSIDER POWER
-10.40
Last 99 transactions
Buy: 490 434 \| Sell: 624 424

Wolumen Korelacja

Długi: -0.52 (weak negative)

Krótki: -0.03 (neutral)

Signal:(49) Neutral

Cytokinetics Inc Korelacja

10 Najbardziej pozytywne korelacje
CCSI	0.884
GOODM	0.883
YTEN	0.882
DORM	0.864
TXMD	0.855
REPL	0.852
DHIL	0.85
AFMD	0.848
PBYI	0.845
HTIA	0.84

10 Najbardziej negatywne korelacje
RMRM	-0.931
IMRA	-0.887
LONE	-0.85
XLRN	-0.847
RESN	-0.844
SPCX	-0.843
JCOM	-0.834
DHC	-0.834
BTBD	-0.831
PLPC	-0.824

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cytokinetics Inc Korelacja - Waluta/Towar

-0.69
( moderate negative )

-0.48
( neutral )

0.00
( neutral )

-0.56
( weak negative )

-0.28
( neutral )

0.16
( neutral )

Cytokinetics Inc Finanse

Annual	2023
Przychody:	$7.53M
Zysk brutto:	$-4.36M (-57.93 %)
EPS:	$-5.45

FY	2023
Przychody:	$7.53M
Zysk brutto:	$-4.36M (-57.93 %)
EPS:	$-5.45

FY	2022
Przychody:	$94.59M
Zysk brutto:	$-146.23M (-154.59 %)
EPS:	$-4.48

FY	2021
Przychody:	$70.43M
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-2.68

Financial Reports:

No articles found.

Cytokinetics Inc

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure; and reldesemtiv, a skeletal muscle troponin activator, which is in Phase III clinical trial to treat amyotrophic lateral sclerosis and spinal muscular atrophy. The company also develops CK-136, a novel cardiac troponin activator that is in Phase I clinical trial; aficamten, a novel cardiac myosin inhibitor, which is in Phase III clinical trial for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy; and CK-3772271, a small molecule cardiac myosin inhibitor that is in Phase I clinical trial. Cytokinetics, Incorporated has a strategic alliance with Astellas Pharma Inc. The company was incorporated in 1997 and is headquartered in South San Francisco, California.

Aktualne aktualizacje dla Cytokinetics Inc [CYTK]

Upcoming Earnings Alert